Conference Coverage

Gabapentin falls short in treating sickle cell pain

Publish date: May 6, 2019

 

REPORTING FROM THE 2019 ASPHO CONFERENCE

SOURCE: Puri L et al. ASPHO 2019, Abstract 2011.

Pages

Recommended Reading

Aplastic Anemia: Current Treatment
MDedge Hematology and Oncology
Single-dose tafenoquine appears to prevent malaria relapse
MDedge Hematology and Oncology
A new era of TTP treatment
MDedge Hematology and Oncology
Novel transplant protocol improves engraftment in severe hemoglobinopathies
MDedge Hematology and Oncology
In sickle cell disease, opioid prescribing starts early, study finds
MDedge Hematology and Oncology
CDC clarifies opioid prescribing guidelines in cancer, sickle cell disease
MDedge Hematology and Oncology
C3 inhibitor shows potential in PNH and AIHA
MDedge Hematology and Oncology
CDC warns against misuse of opioid-prescribing guideline
MDedge Hematology and Oncology
ICYMI: NIH renames, streamlines gene therapy committee
MDedge Hematology and Oncology
LentiGlobin reduces transfusion dependence in young thalassemia patients
MDedge Hematology and Oncology